WEDNESDAY, April 4, 2018 — Testicular cancer survivors (TCS) have metabolic abnormalities characterized by hypertension and increased low-density lipoprotein (LDL) and total cholesterol, according to a study published in the March 1 issue of the Journal of the National Comprehensive Cancer Network.
Mohammad Abu Zaid, M.D., from Indiana University in Indianapolis, and colleagues examined clinical and genetic metabolic syndrome (MetS) risk factors in 486 North American TCS aged <55 years at diagnosis and who received first-line chemotherapy.
The researchers found that, compared with controls, TCS had a higher prevalence of hypertension (43.2 versus 30.7 percent; P < 0.001), but they were less likely to have decreased high-density lipoprotein (HDL) cholesterol levels (23.7 versus 34.8 percent; P < 0.001) or abdominal obesity (28.2 versus 40.1 percent; P < 0.001). The frequency of MetS was similar in TCS and controls (21.0 versus 22.4 percent; P = 0.59), with no difference by treatment (P = 0.20) and no correlation with rs523349 (5-α-reductase gene SRD5A2; P = 0.61). TCS were significantly more likely to have increased LDL cholesterol levels (P < 0.001), total cholesterol levels (P < 0.001), and body mass index ≥25 kg/m² (P = 0.04). There were significant associations for age at evaluation, testosterone level ≤3.0 ng/mL, and elevated soluble cell adhesion molecule-1 level with MetS.
“Metabolic abnormalities in TCS are characterized by hypertension and increased LDL and total cholesterol levels but lower rates of decreased HDL levels and abdominal obesity, signifying possible shifts in fat distribution and fat metabolism,” the authors write.
© 2018 HealthDay. All rights reserved.
Posted: April 2018
April 25, 2018
April 24, 2018
- Studies provide advanced knowledge about renal cancer
- Researchers develop low-cost, portable laboratory on a phone to detect infections
- Early treatment improves leg ulcer healing rates
- U.S. FDA and European Medicines Agency Accept Regulatory Submissions for Review of Dacomitinib to Treat Metastatic Non-Small Cell Lung Cancer with EGFR-Activating Mutations
- Redefined Alzheimer’s biology has implications for drug design
- BetterYou’s Iron Oral Spray recognized as ‘Best New Health and Nutrition Product’
- New imaging technology to effectively screen for colorectal cancer among young adults
- UW developmental psychologist wins 2018 Alan T. Waterman Award
- Adipose-derived mesenchymal stem cells combined with fibrin matrix influences restoration of motor functions
- Exposure to toxin found in sheep may be linked to development of MS
- FDA Approves Intravenous Formulation of Akynzeo (fosnetupitant/palonosetron) for Chemotherapy-Induced Nausea and Vomiting
- Is Alzheimer’s caused by disruptions to the brain’s energy supply?
- Low concentrations of antibiotics can develop high antibiotic resistance in bacteria
- Imagined and real movements have similar brain mechanisms, research suggests
- Alcoholic drinks affect oral bacteria tied to diseases
- Mechanism in Non-Contact ACL Tears Similar in Men, Women
- Buprenorphine may be safer than methadone if treatment duration is longer, study suggests
- NF-κB1 gene known to drive cancer development is critical for preventing stomach cancers
- New tool helps blind, low-vision users navigate modern webpages more easily
- Hippo pathway plays essential role in embryonic development of the mouse heart